tizanidine 6 MG Oral Capsule
1 INDICATIONS AND USAGE Tizanidine hydrochloride is a central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine hydrochloride capsules should be reserved for those daily activities and times when relief of spasticity is most important. ( 1 ) Tizanidine hydrochloride is a central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine hydrochloride capsules should be reserved for those daily activities and times when relief of spasticity is most important [ see Dosage and Administration (2.1) ] .
Zydus Pharmaceuticals (USA) Inc.
CAPSULE PURPLE 1113
Related Pills
tizanidine 4 MG Oral Capsule
Zydus Pharmaceuticals (USA) Inc.
tizanidine 2 MG Oral Capsule
Zydus Pharmaceuticals (USA) Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1
TIZANIDINE HYDROCHLORIDE capsules
TIZANIDINE HYDROCHLORIDE capsules, 2 mg are light yellow to yellow colored granular powder filled in size "5" empty hard gelatin capsule having light blue opaque colored cap imprinted with "1111" in black ink and light blue opaque colored body and are supplied as follows: NDC 70710-1111-8 in bottles of 150 capsules with child-resistant closure NDC 70710-1111-5 in bottles of 500 capsules NDC 70710-1111-4 in unit-dose blister cartons of 100 (10 x 10) unit-dose capsules
TIZANIDINE HYDROCHLORIDE capsules, 4 mg are light yellow to yellow colored granular powder filled in size "3" empty hard gelatin capsule having violet opaque colored cap imprinted with "1112" in white ink and white opaque colored body and are supplied as follows: NDC 70710-1112-8 in bottles of 150 capsules with child-resistant closure NDC 70710-1112-5 in bottles of 500 capsules NDC 70710-1112-4 in unit-dose blister cartons of 100 (10 x 10) unit-dose capsules
TIZANIDINE HYDROCHLORIDE capsules, 6 mg are light yellow to yellow colored granular powder filled in size "2" empty hard gelatin capsule having violet opaque colored cap imprinted with "1113" in white ink and violet opaque colored body and are supplied as follows: NDC 70710-1113-8 in bottles of 150 capsules with child-resistant closure NDC 70710-1113-5 in bottles of 500 capsules NDC 70710-1113-4 in unit-dose blister cartons of 100 (10 x 10) unit-dose capsules Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in containers with child resistant closure.
More pills like CAPSULE 1113